mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.9 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |